Intendis, Inc. Changes Name to Bayer HealthCare (BAY)
1/4/2012 8:04:27 AM
More...
|
Kythera Biopharmaceuticals and Intendis, Inc. Announce Initiation of European Phase III Clinical Development Program to Evaluate ATX-101 for Reduction of Submental Fat
1/10/2011 11:39:16 AM
More...
|
Kythera Biopharmaceuticals and Bayer Corporation (BAY) Unit Intendis, Inc. Enter Licensing and Development Agreement for Adipolytic Agent ATX-101; Kythera To Receive $43 Million Upfront And May Receive $330 Million More
8/30/2010 10:57:13 AM
More...
|
Bayer HealthCare (BAY) and Intendis, Inc. Announce Strategic Alliance to Co-Promote Yaz(R) (Drospirenone/Ethinyl Estradiol) for Treatment of Moderate Acne
5/7/2007 11:59:29 AM
More...
|
Foamix And Intendis, Inc. Sign License Agreement For The Development Of A Dermatological Foam
1/10/2007 10:08:46 AM
More...
|